Dating Startups Pioneer Verification Tools to Combat Fake Profiles
Roundhill Memory ETF Surges 85 Since Debut Becoming FastestGrowing Fund on Record
Nebius Group to Present at BofA Global Technology Conference Potential Catalyst for AIFocused Firm
Kevin Warshs Potential Fed Policy Shift A Slimmer Role in Wall Streets Plumbing
Trump Reverses AI Executive Order Dropping Safety Review Requirement for New Models
Saudi Arabia Faces Mounting Competition for Asian Oil Market Share
NextEra Energy NEE Q1 2026 Earnings EPS Beats Estimates by 125 as Renewable and Regulated Segments Drive Performance
Perdoceo Education Corporation PRDO Q1 2026 Earnings EPS Surpasses Estimates with 5 Surprise
ABX Q1 2026 Earnings Marginal EPS Miss Amid Positive Stock Reaction
GSIT Q1 2026 Earnings Narrower Loss Drives Stock Rally
IDR Q1 2026 Earnings EPS Miss Weighs on Shares as Strategic Priorities Continue
PHI Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Edges Higher
Guardian Metal Resources PLC GMTL Surges 75 Bullish Momentum Builds Above Key Support
Exponent Inc EXPO Climbs Nearly 3 as Stock Approaches Key Resistance
Ategrity Specialty Insurance ASIC Edges Higher Approaching Resistance
Constellium CSTM Rallies 3 Approaching Key Resistance at 3673
Paramount Gold Nevada Corp PZG Slips 148 as Technical Indicators Suggest Potential Consolidation
Lloyds Potential Halifax Brand Retirement Stirs Local and Financial Concerns
CIMN Q1 2026 Earnings EPS Beats Estimates Amid Steady Performance
CRA International CRAI Holds Near 145 as Modest Pullback Tests Support Zone
Yorkville Acquisition Corp Unit MCGAU Holds Steady at 1029 A Static SPAC Unit Under Scrutiny
Navios Maritime Partners NMM Holds Steady Near Support as Shipping Sector Faces Mixed Signals
Lithia Motors LAD Edges Higher Amid Steady Trading Key Levels in Focus
Emergent BioSolutions EBS Slips 142 as Stock Navigates Key Support Levels
Franklin Universal Trust FT Edges Higher Approaching Key Resistance Zone
Waldencast Warrants WALDW Edge Higher at 004 Amid Tight Trading Range
Acumen Pharmaceuticals ABOS Gains Nearly 5 as Stock Tests Resistance at 267